Status:
TERMINATED
Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Dana-Farber Cancer Institute
Conditions:
Multivessel Pulmonary Vein Stenosis
Eligibility:
All Genders
Up to 18 years
Brief Summary
Prospective, single center, descriptive study in 14 infants/children with multivessel pulmonary vein stenosis stratified for patients with or without underlying cardiac disease. Group 1: Patients wit...
Detailed Description
Patients identified at the time of presentation to their cardiologist will be asked to provide a urine sample for analysis. If blood is being drawn for other clinical tests, an extra vial of blood wil...
Eligibility Criteria
Inclusion
- Diagnosis can be based on clinical and radiographic grounds or at the time of biopsy or prior surgical procedures. The diagnosis must be consistent with multivessel pulmonary stenosis.
- There must be evidence of severe pulmonary vein stenosis in at least two pulmonary veins.
- Must give written informed consent according to institutional guidelines
Exclusion
- Mechanism of pulmonary venous obstruction due to obvious anatomic cause, such as extrinsic compression
Key Trial Info
Start Date :
August 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00215059
Start Date
August 1 2000
End Date
July 1 2012
Last Update
August 2 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
2
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02115